潮热的临床试验
总计1515个结果
-
University of California, San Diego完全的
-
University of California, San Diego完全的
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Children's Hospital Medical Center, Cincinnati终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Stem Cell Research Fund终止
-
Washington University School of MedicineIncyte Corporation招聘中
-
Hospital Universitario Dr. Jose E. Gonzalez招聘中
-
University of East AngliaUniversity of Hertfordshire; London South Bank University; Health Education England (East of England) 和其他合作者完全的
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbH; Deutsche Klinik fuer Diagnostik完全的
-
University of Sao Paulo完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); CTI BioPharma完全的
-
Massachusetts General HospitalSeagen Inc.终止
-
Hospital Universitario Dr. Jose E. Gonzalez完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
University of LiegeKU Leuven; Maastricht University Medical Center; University Hospital, Ghent; Queen Fabiola Children... 和其他合作者招聘中
-
Ann & Robert H Lurie Children's Hospital of Chicago完全的
-
Jennifer E. SchwartzMillennium Pharmaceuticals, Inc.完全的
-
Novartis Pharmaceuticals主动,不招人移植物抗宿主病日本, 斯洛伐克, 台湾, 西班牙, 大韩民国, 泰国, 加拿大, 俄罗斯联邦, 意大利, 火鸡, 印度, 捷克语, 巴西, 瑞士
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.撤销
-
Dana-Farber Cancer InstituteBiogen完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.完全的
-
Dana-Farber Cancer Institute完全的
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.终止
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
University of Michigan完全的